This rationale follows the correlation demonstrated between maximum SUV and an increased expression of glucose transporters 1 and p53 for adenocarcinoma NSCLC patients, but not squamous cell by the work of Taylor et al. [49]. This evidence concerns the gene TP53 and adenocarcinoma.